Fentanyl Crisis Research and Evaluation Act

Hozzl · 2024-03-08T15:30:54Z

Explore the details of House Bill 5237 Fentanyl Crisis Research and Evaluation Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

3/8/2024, 3:30 PM

Summary of Bill HR 5237

Bill 118 HR 5237, also known as the Fentanyl Crisis Research and Evaluation Act, is a piece of legislation introduced in the US Congress aimed at addressing the growing crisis surrounding the use and distribution of the synthetic opioid fentanyl.

The bill proposes to allocate funding for research and evaluation of the fentanyl crisis, with a focus on understanding the causes of the crisis, identifying effective prevention and treatment strategies, and evaluating the impact of current policies and programs.

Additionally, the bill seeks to enhance coordination and collaboration among federal, state, and local agencies involved in combating the fentanyl crisis, in order to improve the effectiveness of efforts to address the issue. Overall, the Fentanyl Crisis Research and Evaluation Act aims to provide a comprehensive and evidence-based approach to addressing the fentanyl crisis, with the ultimate goal of reducing the harm caused by this dangerous drug.

Congressional Summary of HR 5237

Fentanyl Crisis Research and Evaluation Act

This bill requires the Government Accountability Office to report on the fentanyl crisis, including with respect to the effects on government programs and finances.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5237

Bill HR 5237 is currently in the status of Bill Introduced since August 18, 2023. Bill HR 5237 was introduced during Congress 118 and was introduced to the House on August 18, 2023. Bill HR 5237's most recent activity was Referred to the Subcommittee on Health. as of August 25, 2023